Inventor · disambiguated record
Elisabeth Pook
Also filed as: POOK ELISABETH
23 granted patents·15 pending applications·70 citations·filing 2006–2023
93Inventor score
Top patents by PatentIndex Score
38 records- 0192US9988367B2Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Jun 5, 2018·5 cites·14 claims
- 0288US9687476B2Bisaryl-bonded aryltriazolones and use thereofBAYER IP GMBH·Filed 2015·Granted Jun 27, 2017·8 cites·6 claims
- 0387US9771352B2Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2015·Granted Sep 26, 2017·8 cites·15 claims
- 0484US10526314B2Hydroxyalkyl-substituted heteroaryltriazole derivatives and uses thereofBAYER AG·Filed 2017·Granted Jan 7, 2020·3 cites·6 claims
- 0584US10472348B2Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Granted Nov 12, 2019·3 cites·12 claims
- 0683US8084481B2Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptorsMEIER HEINRICH·Filed 2007·Granted Dec 27, 2011·11 cites·11 claims
- 0782US8202895B2Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereofBRUEGGEMEIER ULF·Filed 2010·Granted Jun 19, 2012·13 cites·30 claims
- 0879US10525041B2Fluoroalkyl-substituted aryltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Jan 7, 2020·3 cites·13 claims
- 0979US8796324B2Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereofBRÜGGEMEIER ULF·Filed 2012·Granted Aug 5, 2014·6 cites·8 claims
- 1076US10815205B2Amide-substituted phenyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Oct 27, 2020·2 cites·13 claims
- 1173US9187466B2Bisaryl-bonded aryltriazolones and use thereofFURSTNER CHANTAL·Filed 2011·Granted Nov 17, 2015·4 cites·9 claims
- 1272US9180120B2Substituted N-phenethyltriazoloneacetamides and use thereofFÜRSTNER CHANTAL·Filed 2011·Granted Nov 10, 2015·3 cites·3 claims
- 1370US11091463B2Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2019·Granted Aug 17, 2021·0 cites·9 claims
- 1464US9034855B2Substituted phenylacetate and phenylpropane amides and use thereofFÜRSTNER CHANTAL·Filed 2011·Granted May 19, 2015·1 cites·8 claims
- 1564US2019144423A1Amide-substituted pyridinyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Application pending·0 cites
- 1662US2024109850A1Covalent PPARG inverse-agonistsBAYER AG·Filed 2023·Application pending·0 cites
- 1762US2024150277A1Covalent PPARG inverse-agonistsBAYER AG·Filed 2023·Application pending·0 cites
- 1851US2023257351A1Substituted n-phenylacetamides having p2x4 receptor antagonistic activityBAYER AG·Filed 2021·Application pending·0 cites
- 1950US8859601B2Substituted benzyl and phenylsulfonyl triazolones, and use thereofBRÜGGEMEIER ULF·Filed 2009·Granted Oct 14, 2014·0 cites·7 claims
- 2050US2011183928A13-Cyanoalkyl- and 3-hydroxyalkylindoles and use thereofBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 2149US10800746B2Oxoalkyl-substituted phenyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Oct 13, 2020·0 cites·12 claims
- 2249US2021253557A1Substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Application pending·0 cites
- 2348US11149023B2Substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Granted Oct 19, 2021·0 cites·11 claims
- 2448US2023013419A1Analogues of 3-(5-methyl-1,3-thiazol-2-yl)-n-{(1r)-1-[2-(trifluoro-methyl)pyrimidin-5-yl]ethyl}benzamideBAYER AG·Filed 2020·Application pending·0 cites
- 2546US11331314B2Amine substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Granted May 17, 2022·0 cites·11 claims
- 2646US10927098B2Hydroxyalkyl-substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Granted Feb 23, 2021·0 cites·11 claims
- 2746US2013005704A1Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptorsBAYER PHARMA AKTIENGESELLSHAFT·Filed 2011·Application pending·0 cites
- 2844US11298367B2Prodrugs of substituted triazole derivatives and uses thereofBAYER AG·Filed 2018·Granted Apr 12, 2022·0 cites·12 claims
- 2944US11230540B2Substituted triazole derivatives and uses thereofBayer Pharma AG·Filed 2018·Granted Jan 25, 2022·0 cites·13 claims
- 3042US11173151B2Substituted triazole derivatives and uses thereofBAYER AG·Filed 2018·Granted Nov 16, 2021·0 cites·13 claims
- 3142US2022324865A1Substituted dihydropyrazolo pyrazine carboxamide derivativesBAYER AG·Filed 2019·Application pending·0 cites
- 3242US2008194598A1Pyrimidine Carboxylic Acid Derivatives and Use ThereofBAYER HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 3341US2017313665A1Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereofBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3440US11319324B2Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitorsBAYER AG·Filed 2018·Granted May 3, 2022·0 cites·11 claims
- 3539US2019119251A1Amide-substituted aryltriazole derivatives and uses thereofBayer Pharma AG·Filed 2017·Application pending·0 cites
- 3635US2012208852A1Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereofFUERSTNER CHANTAL·Filed 2010·Application pending·0 cites
- 3733US2018338980A1Aromatic sulfonamide derivativesBayer Pharma AG·Filed 2016·Application pending·0 cites
- 3829US2012053218A1Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiencyBRUEGGEMEIER ULF·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elisabeth Pook files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →